Analysis of BRCA samples from various clinical subtypes in the TCGA revealed substantial correlations between MDH2 transcript levels and breast cancer subtype, pathological T stage, human epidermal growth factor receptor 2 (HER2) status, estrogen receptor (ER) status, progesterone receptor (PR) status, race, and histological type. Here, MDH2 is linked to breast cancer.